Font Size: a A A
Keyword [HER-2 positive]
Result: 1 - 20 | Page: 1 of 3
1. Antitumor Activity Of Targeted Recombinant Human AIF On HER-2 Positive Carcinoma
2. Role Of CEA,CA125,CA15-3 In Predicting Response Of Biochemotherapy In Her-2-positive Advanced Breast Cancer
3. Cai A Mixture Of Addition And Subtraction Treatment Of Her-2 Positive Breast Cancer, The Efficacy Of Clinical Research
4. The Effect Of Celecoxib On Proliferation And Apoptosis In Her-2/positive Human Gastric Cancer Cell NCI-N87
5. Effects Of Trastuzumab Plus Chemoheraphy For The HER-2-positive Advanced Gastric Cancer Patients:a Meta‐analysis
6. The Role Of TIP30and Egfr In HER-2-positive Advanced Breast Cancer And Its Clinical Significance
7. The Pathological Characteristics Of Metastasis And Anti-Metastasis Effects Of BRACs On HER-2 Positive Cancer
8. Black Rice Anthocyanins Inhibit HER-2-Positive Breast Cancer Epithelial–Mesenchymal Transition And Cell Metastasis Via FAK Signaling In Vitro
9. Effects Of Notch Signaling Pathway Inhibitor On Her-2 Positive Cell Lines SK-BR3 With Stem Cells Properties
10. Evaluation On Efficacy Of Trastuzumab In Her-2 Positive Breast Cancer Patients And Its Analysis Of Prognosis Influencing Factors
11. Prognostic Analysis Of Targeted Therapy On T1 Stage HER-2 Positive Breast Cancer
12. Study Of Expression Of BRCA1,FANCF,CD44+CD24- In Triple Negative And Luminal B (Her-2 Positive) Breast Cancer
13. The Clinical Observation Of Trastuzumab In First-line Treatment Of Her-2 Positive Metastatic Breast Cancer
14. The Role And Molecular Mechanism Of Autophahgy In Delphinidin-induced Anticancer Effects For HER-2 Positive Breast Cancer
15. Experimental Study Of Brain-Targeted Compound Nano Micelles In The Treatment Of Brain Metastases From HER-2-positive Breast Cancer
16. Analysis Of The Clinical And Pathological Features Of The HER-2 Positive Breast Cancer
17. The Predictive Value Of Tils For Trastuzumab In Her-2 Positive Breast Cancer
18. Comparison Of Efficacy Of THL And TCH Regimen In Neoadjuvant Treatment Of Her-2 Positive Breast Cancer
19. RBM38 Induces Tarstuzumab Sensitivity In HER-2 Positive Breast Cancer By Increasing The Expression Of HER-2
20. Advance In Molecular Targeted Therapy For HER-2 Positive Breast Cancer
  <<First  <Prev  Next>  Last>>  Jump to